Capillarization of the sinusoids in liver fibrosis: Noninvasive assessment with contrast-enhanced MRI in the rabbit

Magnetic Resonance in Medicine

Volumn 49, Issue 4, 2003, Pages 692-699

  Van Beers, Bernard E ^a   Materne, Roland ^a   Annet, Laurence ^a   Hermoye, Laurent ^a   Sempoux, Christine ^a   Peeters, Frank ^a   Smith, Anne M ^a   Jamart, Jacques ^b   Horsmans, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Contrast media; Liver blood supply; Liver cirrhosis; Physiopathology

Indexed keywords

MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; MOLECULAR WEIGHT; NONINVASIVE MEDICAL PROCEDURES;

BLOOD SUPPLY; CONTRAST-ENHANCED; DISTRIBUTION VOLUME; HIGH MOLECULAR WEIGHT; LIVER CIRRHOSIS; LOW MOLECULAR WEIGHT; NON-INVASIVE ASSESSMENTS; PHYSIOPATHOLOGY;

CONTRAST MEDIA;

CHOLESTEROL; COLLAGEN; CONTRAST MEDIUM; DIETHYLSTILBESTROL; GADOTERIC ACID; INDOCYANINE GREEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER SINUSOID; MALE; MICROCIRCULATION; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT;

EID: 0037382467     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10420     Document Type: Article

References (40)

1. Keiding S. Drug administration to liver patients: aspects of liver pathophysiology. Semin Liver Dis 1995;15:268-282.
2. Huet PM, Pomier-Layrargues G, Villeneuve JP, Varin F, Viallet A. Intrahepatic circulation in liver disease. Semin Liver Dis 1986;6:277-286.
3. Reichen J, Egger B, Ohara N, Zeltner TB, Zysset T, Zimmermann A. Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis. J Clin Invest 1988;82:2069-2076.
4. Morgan DJ, McLean AJ. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. Clin Pharmacokinet 1995;29:370-391.
5. Mastai R, Laganiere S, Wanless IR, Giroux L, Rocheleau B, Huet PM. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit. II. Hemodynamic and drug disposition studies. Hepatology 1996;24:865-870.
6. Schaffner F, Popper H, Capillarization of hepatic sinusoids in man. Gastroenterology 1963;44:239-242.
7. Huet PM, Goresky CA, Villeneuve JP, Marleau D, Lough JO. Assessment of liver microcirculation in human cirrhosis. J Clin Invest 1982;70:1234-1244.
8. Varin F, Huet PM. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest 1985;76:1904-1912.
9. Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D. The hepatic microcirculation in the isolated perfused human liver. Hepatology 1996;23:24-31.
10. Materne R, Smith AM, Peeters F, Dehoux JP, Keyeux A, Horsmans Y, Van Beers BE. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002;47:135-142.
11. Wanless IR, Belgiorno J, Huet PM. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit. I. Morphology and inhibition of fibrogenesis by dipyridamole. Hepatology 1996;24:855-864.
12. Marbaix E, Kokorine I, Moulin P, Donnez J, Eeckhout Y, Courtoy PJ. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci USA 1996;93:9120-9125.
13. Plevris JN, Jalan R, Bzeizi KI, Dollinger MM, Lee A, Garden OJ, Hayes PC. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 1999;30:142-148.
14. Corot C, Schaefer M, Beaute S, Bourrinet P, Zehf S, Benize V, Sabatou M, Meyer D. Physical, chemical and biological evaluations of CMD-A2Gd-DOTA. A new paramagnetic dextran polymer. Acta Radiol Suppl 1997;412:91-99.
15. Corot C, Violas X, Robert P, Port M. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography. Invest Radiol 2000;35:213-218.
16. Port M, Corot C, Raynal I, Idee JM, Dencausse A, Lancelot E, Meyer D, Bonnemain B, Lautrou J. Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Invest Radiol 2001;36:445-454.
17. Idee JM, Berthommier C, Goulas V, Corot C, Santus R, Hermine C, Schaefer M, Bonnemain B. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation. Biometals 1998;11:113-123.
18. Materne R, Van Beers BE, Smith AM, Leconte I, Jamart J, Dehoux JP, Keyeux A, Horsmans Y. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci 2000;99:517-525.
19. Vallee JP, Lazeyras F, Kasuboski L, Chatelain P, Howarth N, Righetti A, Didier D. Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function. J Magn Reson Imaging 1999;9:197-203.
20. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
21. Landis CS, Li X, Telang FW, Coderre JA, Micca PL, Rooney WD, Latour LL, Vetek G, Palyka I, Springer CS. Determination of the MRI contrast concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000;44:563-574.
22. Stanisz GJ, Henkalman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000;44:665-667.
23. Ziegler SI, Haberkorn U, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P. Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med 1996;23:169-177.
24. Vallee JP, Sostman HD, MacFall JR, Wheeler T, Hedlund LW, Spritzer CE, Coleman RE. MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study. Magn Reson Med 1997;38:981-989.
25. 1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
26. Marquardt DW. An algorithm for least squares estimation of non-linear parameters. J Soc Ind Appl Math 1963;11:431-441.
27. Murata K, Ochiai, Akashio K. Polydispersity of acidic glycosaminoglycan components in human liver and the changes at different stages in liver cirrhosis. Gastroenterology 1985;89:1248-1257.
28. Nugent LJ, Jain RK. Extravascular diffusion in normal and neoplastic tissues. Cancer Res 1984;44:238-244.
29. Molino G, Avagnina P, Belforte G, Bircher J. Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method. J Lab Clin Med 1998;131:393-405.
30. Skak C, Keiding S. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 1987;7:155-162.
31. Keiding S, Engsted E, Ott P. Sorbitol as a test substance for measurement of liver plasma flow in humans. Hepatology 1998;28:50-56.
32. Ott P, Clemmesen O, Keiding S. Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization? Dig Dis Sci 2000;45:359-365.
33. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Roentgenol 2001;176:667-673.
34. Materne R, Annet L, Dechambre S, Sempoux C, Smith AM, Corot C, Horsmans Y, Van Beers BE. Dynamic computed tomography with lowand high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. Clin Sci 2002;103:213-216.
35. Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997;205:716-720.
36. Peeters F, Annet L, Hermoye L, Van Beers BE. Inflow effects in TFEimages with application to perfusion measurements. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, 2002. p 2303.
37. Morgan DJ, Smallwood RA. Clinical significance of pharmacokinetic models of hepatic elimination. Clin Pharmacokinet 1990;18:61-76.
38. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W, Regional blood flow. capillary permeability, and compartmental volumes: measurement with dynamic CT. Initial experience. Radiology 1999;210:269-276.
39. Wyatt JD, Scott RA, Richardson ME. The effects of prolonged ketaminexylazine intravenous infusion on arterial blood pH, blood gases, mean arterial blood pressure, heart and respiratory rates, rectal temperature and reflexes in the rabbit. Lab Anim Sci 1989;39:411-416.
40. Gaillard S, Kubiak C, Stolz C, Bonnemain B, Chassard D. Safety and pharmacokinetics of P792, a new blood-pool agent: results of clinical testing in nonpatient volunteers. Invest Radiol 2002;37:161-166.